Physician Profile

Michael A. Azrin, M.D., FACC, FSCAI, FAHA

Professor of Medicine
Director, Cardiac Catheterization and Interventional Cardiology
Program Director, Interventional Cardiology Fellowship
Associate Director, Clinical Program and Research Development

Dr. Azrin is a fellow of the American College of Cardiology and the American Heart Association (AHA). He also serves on the AHA Arteriosclerosis, Thrombosis and Vascular Biology Council.

Office Locations:

Pat and Jim Calhoun Cardiology Center
UConn Health
263 Farmington Avenue
Farmington, CT 06030

Board Certifications:
  • Internal Medicine
  • Cardiovascular Disease
  • Interventional Cardiology
Education and Training:
Undergraduate SchoolBrandeis UniversityBiology
Medical SchoolWashington University School of MedicineMedicine
InternshipJewish Hospital of Washington UniversityInternal Medicine
ResidencyJewish Hospital of Washington UniversityInternal Medicine
FellowshipYale UniversityClinical Cardiology
FellowshipHartford HospitalInterventional Cardiology
Honors and Awards:
Name of Award/HonorAwarding Organization
Best Doctors 2009-2012 Hartford Magazine
America’s Top Doctors 2008-13Castle Connelly
Fellow, Thrombosis and Vascular BiologyAmerican Heart Association Council on Arteriosclerosis
FellowAmerican College of Cardiology
CAMEL Award (Committee Award for Meritorious Educational Leadership) Cardiovascular Subject CommitteeUConn Health Center
Young Investigator's Award Competition Finalist: More RJ, Azrin MA, DeBono DP, Ezekowitz MD, Gershlick AH: Reduction in Intimal Hyperplasia After Experimental Angioplasty by a Locally Delivered Targeted Antiplatelet-fibrinolytic Aagent American Heart Association
Hospital Affiliation:
  • UConn John Dempsey Hospital
Selected Publications:

Peer Reviewed Publications

Transulnar versus transradial access for coronary angiography or percutaneous coronary intervention: A meta-analysis of randomized controlled trials. Dahal, Khagendra; Rijal, Jharendra; Lee, Juyong; Korr, Kenneth S; Azrin, Michael. (2015). Catheterization and cardiovascular interventions : official journal of the Society for Cardiac Angiography & Interventions,

Multi-vessel versus culprit-vessel and staged percutaneous coronary intervention in STEMI patients with multivessel disease: a meta-analysis of randomized controlled trials. Dahal, Khagendra; Rijal, Jharendra; Panta, Raju; Lee, Juyong; Azrin, Michael; Lootens, Robert. (2014). Cardiovascular revascularization medicine : including molecular interventions, 8, (15), 408-13.

Exercise during cardiac catheterization distinguishes between pulmonary and left ventricular causes of dyspnea in systemic sclerosis patients. Hager, W David; Collins, Irina; Tate, Janet P; Azrin, Michael; Foley, Raymond; Lakshminarayanan, Santha; Rothfield, Naomi F. (2013). The clinical respiratory journal, 3, (7), 227-36.

Survival of geriatric idiopathic pulmonary arterial hypertension patients. Foley, Raymond J; Wilcox, Diahann; Walsh, Stephen J; Azrin, Michael; Hager, W David. (2011). Connecticut medicine, 1, (75), 11-5.

Rheolytic thrombectomy with percutaneous coronary intervention for infarct size reduction in acute myocardial infarction: 30-day results from a multicenter randomized study. Ali, Arshad; Cox, David; Dib, Nabil; Brodie, Bruce; Berman, Daniel; Gupta, Navin; Browne, Kevin; Iwaoka, Robert; Azrin, Michael; Stapleton, Dwight; Setum, Cindy; Popma, Jeffrey. (2006). Journal of the American College of Cardiology, 2, (48), 244-52.